Shigeharu Myou
The Third Department of Internal Medicine
Kanazawa University School of Medicine
Kanazawa
Japan
Name/email consistency: high
- Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients. Myou, S., Fujimura, M., Kamio, Y., Hirose, T., Kita, T., Tachibana, H., Ishiura, Y., Watanabe, K., Hashimoto, T., Nakao, S. Br. J. Clin. Pharmacol (2003)
- Effect of ozagrel hydrochloride, a thromboxane synthetase inhibitor, on alcoholic beverage-induced bronchoconstriction in asthmatic patients. Myou, S., Fujimura, M., Nishi, K., Kita, T., Kurashima, K., Tachibana, H., Ishiura, Y., Nakao, S. Prostaglandins Leukot. Essent. Fatty Acids (2002)
- Effect of intranasal administration of CV-11974, a type 1 angiotensin II receptor antagonist, on airway hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea pigs. Myou, S., Fujimura, M., Kita, T., Watanabe, K., Hirose, T., Tachibana, H., Ishiura, Y., Nakao, S. Int. Arch. Allergy Immunol. (2002)
- Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. Myou, S., Fujimura, M., Kamio, Y., Kita, T., Watanabe, K., Ishiura, Y., Hashimoto, T., Nakao, S. Br. J. Clin. Pharmacol (2002)
- Effect of a cysteinyl leukotriene antagonist, pranlukast hydrate, on acetaldehyde-induced bronchoconstriction in asthmatic patients. Myou, S., Fujimura, M., Kamio, Y., Kita, T., Katayama, N., Abo, M., Yoshimi, Y., Nishitsuji, M., Nomura, S., Hashimoto, T., Nakao, S. Prostaglandins Leukot. Essent. Fatty Acids (2001)
